Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Katrin M. Kirschbaum"'
Autor:
Ulrich Schmitt, Manisha Kusch-Poddar, Heike Gutmann, Christoph Hiemke, Katrin M. Kirschbaum, Jürgen Drewe, Birk Poller
Publikováno v:
Pharmacology Biochemistry and Behavior. 102:312-320
Background P-glycoprotein (P-gp), an efflux transporter of the blood–brain barrier, limits the access of multiple xenobiotics to the central nervous system (CNS). Thus drug-dependent inhibition, induction or genetic variation of P-gp impacts drug t
Publikováno v:
Forensic Science International. 215:60-63
A preliminary initial enzyme-linked immunosorbent assay (LUCIO ® -Direct ELISA kit) and a preliminary DRI ® enzyme immunoassay were evaluated for drug detection in head hair with respect to lowered cutoff values recommended in Germany for the contr
Publikováno v:
Journal of Analytical Toxicology. 35:124-128
Quaternary ammonium compounds pose an analytical challenge. Mebezonium, a muscle-relaxing agent contained in veterinary euthanasia solution T61, was analyzed in body fluids, organs, and injection sites of a veterinarian by liquid chromatography-tande
Autor:
Ulrich Schmitt, Manfred Uhr, Katrin M. Kirschbaum, Christian Namendorf, David Holthoewer, Claus U. Pietrzik, Christoph Hiemke
Publikováno v:
Neuropharmacology. 59:474-479
Background P-glycoprotein (P-gp), an efflux transporter localized in the blood–brain barrier, limits the access of multiple xenobiotics to the central nervous system (CNS). For the new antipsychotic aripiprazole and its active metabolite dehydroari
Publikováno v:
Forensic Science International. 189:e37-e40
The case of a 13-month-old boy with a diagnosis of unclear unconsciousness is reported on. As the physical examination did not lead to any explanation of his condition, the administration of drugs in the context of Munchausen syndrome by proxy was su
Autor:
Katja M Spreckelmeyer, Hildegard Janouschek, Katrin M. Kirschbaum, Gerhard Gründer, Anno Bröcheler, Ingo Vernaleken, Sandra Hellmann, Christian Boy, Christoph Hiemke, Frank Rösch, Christine Fellows, Wolfgang M. Schaefer, Tanja Veselinović
Publikováno v:
American Journal of Psychiatry. 165:988-995
Aripiprazole at clinically effective doses occupies some 90% of striatal dopamine 2 and 3 (D(2)/D(3)) receptors. In order to further characterize its extrastriatal and time-dependent binding characteristics, the authors conducted positron emission to
Publikováno v:
Behavioural Brain Research. 188:298-303
Efflux transporters, like P-glycoprotein (P-gp), may limit the access of drugs to the brain via the blood-brain barrier. The antipsychotic drug risperidone and its active metabolite 9-hydroxyrisperidone (paliperidone) are substrates of P-gp. Motor be
Autor:
Manfred Gerlach, Friederike Vogel, Peter Riederer, Christoph Hiemke, Katrin M. Kirschbaum, Susann Finger, R. Burger
Publikováno v:
Chromatographia. 67:321-324
An automated high performance liquid chromatography with column-switching and ultraviolet detection was developed for the analysis of risperidone and 9-hydroxyrisperidone. The method needs minimum sample preparation and is useful for the detection do
Autor:
Jaroslav Malevani, Katrin M. Kirschbaum, Matthias J. Müller, Markus Piel, Arian Mobascher, Christoph Hiemke, Carsten Burchardt
Publikováno v:
The World Journal of Biological Psychiatry. 9:212-218
Aripiprazole, a novel antipsychotic drug, is metabolized by CYP3A4 and CYP2D6 forming mainly its active metabolite dehydroaripiprazole. In this study, aripiprazole and dehydroaripiprazole serum levels of psychiatric patients were measured and related
Autor:
Alois Saria, Matthias J. Müller, Jaroslav Malevani, Gerald Zernig, Christoph Hiemke, Katrin M. Kirschbaum, Arian Mobascher
Publikováno v:
Clinical Chemistry. 51:1718-1721
Aripiprazole is a novel atypical antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders (1)(2)(3). The drug is metabolized by the cytochrome P450 isoenzymes 3A4 and 2D6 (4). Because of high interindividual variability in